Zimmer Biomet Holdings Inc ZBH
The next Zimmer Biomet Holdings Inc dividend is expected to go ex in 25 days and to be paid in 2 months.
The previous Zimmer Biomet Holdings Inc dividend was 24c and it went ex 2 months ago and it was paid 29 days ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 8.0.
|Summary||Previous dividend||Next dividend|
|Per share||24c||Sign Up Required|
|Declaration date||10 Sep 2020 (Thu)||14 Dec 2020 (Mon)|
|Ex-div date||29 Sep 2020 (Tue)||23 Dec 2020 (Wed)|
|Pay date||30 Oct 2020 (Fri)||29 Jan 2021 (Fri)|
Enter the number of Zimmer Biomet Holdings Inc shares you hold and we'll calculate your dividend payments:
Sign up for Zimmer Biomet Holdings Inc and we'll email you the dividend information when they declare.
Add Zimmer Biomet Holdings Inc to receive free notifications when they declare their dividends.
Your account is set up to receive Zimmer Biomet Holdings Inc notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Quarterly||09 Dec 2024||26 Dec 2024||24 Jan 2025||USD||Sign up||—|
|Forecast||Quarterly||05 Sep 2024||24 Sep 2024||25 Oct 2024||USD||Sign up||—|
|Forecast||Quarterly||06 Jun 2024||21 Jun 2024||26 Jul 2024||USD||Sign up||—|
|Forecast||Quarterly||05 Mar 2024||28 Mar 2024||25 Apr 2024||USD||Sign up||—|
|Forecast||Quarterly||11 Dec 2023||28 Dec 2023||26 Jan 2024||USD||Sign up||—|
|Forecast||Quarterly||07 Sep 2023||26 Sep 2023||27 Oct 2023||USD||Sign up||—|
|Forecast||Quarterly||08 Jun 2023||23 Jun 2023||28 Jul 2023||USD||Sign up||—|
|Forecast||Quarterly||07 Mar 2023||30 Mar 2023||27 Apr 2023||USD||Sign up||—|
|Forecast||Quarterly||12 Dec 2022||29 Dec 2022||27 Jan 2023||USD||Sign up||—|
|Forecast||Quarterly||08 Sep 2022||27 Sep 2022||28 Oct 2022||USD||Sign up||—|
|Forecast||Quarterly||09 Jun 2022||24 Jun 2022||29 Jul 2022||USD||Sign up||—|
|Forecast||Quarterly||08 Mar 2022||24 Mar 2022||28 Apr 2022||USD||Sign up||—|
|Forecast||Quarterly||13 Dec 2021||22 Dec 2021||28 Jan 2022||USD||Sign up||—|
|Forecast||Quarterly||09 Sep 2021||28 Sep 2021||29 Oct 2021||USD||Sign up||—|
|Forecast||Quarterly||10 Jun 2021||25 Jun 2021||30 Jul 2021||USD||Sign up||—|
|Forecast||Quarterly||09 Mar 2021||25 Mar 2021||29 Apr 2021||USD||Sign up||—|
|Forecast||Quarterly||14 Dec 2020||23 Dec 2020||29 Jan 2021||USD||Sign up||—|
|Paid||Quarterly||10 Sep 2020||29 Sep 2020||30 Oct 2020||USD||24c||24c||😄|
|Paid||Quarterly||11 Jun 2020||26 Jun 2020||31 Jul 2020||USD||24c||24c||😄|
|Paid||Quarterly||10 Mar 2020||26 Mar 2020||30 Apr 2020||USD||24c||24c||😄|
|Paid||Quarterly||16 Dec 2019||26 Dec 2019||31 Jan 2020||USD||24c||24c||😄|
|Paid||Quarterly||03 Sep 2019||27 Sep 2019||31 Oct 2019||USD||24c||24c||😄|
|Paid||Quarterly||11 Jun 2019||27 Jun 2019||31 Jul 2019||USD||—||24c|
|Paid||Quarterly||07 Mar 2019||28 Mar 2019||30 Apr 2019||USD||—||24c|
|Paid||Quarterly||12 Dec 2018||27 Dec 2018||31 Jan 2019||USD||—||24c|
|Paid||Quarterly||13 Sep 2018||27 Sep 2018||31 Oct 2018||USD||—||24c|
|Paid||Quarterly||14 Jun 2018||28 Jun 2018||31 Jul 2018||USD||—||24c|
|Paid||Quarterly||12 Mar 2018||28 Mar 2018||30 Apr 2018||USD||—||24c|
|Paid||Quarterly||18 Dec 2017||28 Dec 2017||29 Jan 2018||USD||—||24c|
|Paid||Quarterly||07 Aug 2017||21 Sep 2017||27 Oct 2017||USD||—||24c|
|Paid||Quarterly||30 May 2017||21 Jun 2017||28 Jul 2017||USD||—||24c|
|Paid||Quarterly||01 Mar 2017||29 Mar 2017||28 Apr 2017||USD||—||24c|
|Paid||Quarterly||19 Dec 2016||28 Dec 2016||27 Jan 2017||USD||—||24c|
|Paid||Quarterly||23 Aug 2016||21 Sep 2016||28 Oct 2016||USD||—||24c|
|Paid||Quarterly||–||22 Jun 2016||29 Jul 2016||USD||—||24c|
|Paid||Quarterly||24 Feb 2016||29 Mar 2016||29 Apr 2016||USD||—||24c|
|Paid||Quarterly||14 Dec 2015||29 Dec 2015||29 Jan 2016||USD||—||22c|
|Paid||Quarterly||24 Aug 2015||28 Sep 2015||30 Oct 2015||USD||—||22c|
|Paid||Quarterly||05 May 2015||13 May 2015||14 Jul 2015||USD||—||22c|
|Paid||Quarterly||20 Feb 2015||04 Mar 2015||24 Apr 2015||USD||—||22c|
|Paid||Quarterly||12 Dec 2014||24 Dec 2014||30 Jan 2015||USD||—||22c|
|Paid||Quarterly||26 Aug 2014||24 Sep 2014||31 Oct 2014||USD||—||22c|
|Paid||Quarterly||06 May 2014||25 Jun 2014||25 Jul 2014||USD||—||22c|
|Paid||Quarterly||28 Feb 2014||26 Mar 2014||25 Apr 2014||USD||—||22c|
|Paid||Quarterly||13 Dec 2013||24 Dec 2013||31 Jan 2014||USD||—||20c|
|Paid||Quarterly||15 Jul 2013||25 Sep 2013||25 Oct 2013||USD||—||20c|
|Paid||Quarterly||07 May 2013||26 Jun 2013||26 Jul 2013||USD||—||20c|
|Paid||Quarterly||22 Feb 2013||26 Mar 2013||26 Apr 2013||USD||—||20c|
|Paid||Quarterly||11 Dec 2012||24 Dec 2012||25 Jan 2013||USD||—||18c|
|Paid||Quarterly||–||25 Sep 2012||26 Oct 2012||USD||—||18c|
|Paid||Quarterly||–||26 Jun 2012||27 Jul 2012||USD||—||18c|
|2020||Sign Up Required|
|2021||Sign Up Required|
|2022||Sign Up Required|
|2023||Sign Up Required|
|2024||Sign Up Required|
Zimmer Biomet Holdings Inc Optimized Dividend Chart
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., incorporated on January 12, 2001, is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
The Company's total knee replacement surgeries include a femoral component, a patella (knee cap), a tibial tray and an articular surface. Knee replacement surgeries include first-time, or primary, joint replacement procedures and revision procedures for the replacement, repair or enhancement of an implant or component from a previous procedure. Its knee portfolio also includes early intervention and joint preservation products, which seeks to preserve the joint by repairing or regenerating damaged tissues and by treating osteoarthritis. Its knee brands include Persona The Personalized Knee System, NexGen Complete Knee Solution, Vanguard Knee System and Oxford Partial Knee.
The Company's total hip replacement surgeries replace both the head of the femur and the socket portion of the pelvis (acetabulum) of the natural hip. Hip procedures include first-time, or primary joint replacement, as well as revision procedures. Its hip brands include Zimmer M/L Taper Hip Prosthesis, Taperloc Hip System, Arcos Modular Hip System, Continuum Acetabular System and G7 Acetabular System.
The Company's S.E.T. product category includes surgical, sports medicine, biologics, foot and ankle, extremities and trauma products. Its surgical products are used to support various surgical procedures. Its sports medicine products are primarily for the repair of soft tissue injuries, which are used in the knee and shoulder. Its biologics products are used as early intervention for joint preservation or to support surgical procedures. Its foot and ankle and extremities products are designed to treat arthritic conditions and fractures in the foot, ankle, shoulder, elbow and wrist. Its trauma products are used to stabilize damaged or broken bones and their surrounding tissues to support the body's natural healing process. Its S.E.T. brands include Transposal and Transposal Ultra Fluid Waste Management Systems, A.T.S. Automatic Tourniquet Systems, JuggerKnot Soft Anchor System, Gel-One 1 Cross-linked Hyaluronate, Trabecular Metal Reverse Shoulder System, Comprehensive Shoulder, Zimmer Natural Nail System and DVR Plating System.
Spine and CMF
The Company's spine products division designs, manufactures and distributes medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities or traumatic injury of the spine. Its CMF division includes face and skull reconstruction products as well as products that fixate and stabilize the bones of the chest in order to facilitate healing or reconstruction after open heart surgery, trauma or for deformities of the chest. Its spine and CMF brands include Polaris Spinal System, Timberline Lateral Fusion System, Mobi-C Cervical Disc, SternaLock Blu Closure System and SternaLock Rigid Sternal Fixation.
The Company's dental products division manufactures and/or distributes dental reconstructive implants for individuals who are totally without teeth or are missing one or more teeth; dental prosthetic products targeted at providing a natural restoration to resemble the original teeth, and dental regenerative products for soft tissue and bone rehabilitation. Its dental brands include Tapered Screw-Vent Implant System, 3i T3 Implant and Puros Allograft Products.
The Company's other product category primarily includes its bone cement and bone healing products. Its brands include PALACOS 2 Bone Cement and SpinalPak Spinal Fusion Stimulator.
The Company competes with Johnson & Johnson, Stryker Corporation, Smith & Nephew plc, NuVasive, Inc., Globus Medical, Inc., Danaher Corporation, Straumann Holding AG and Dentsply International.
- Health Care Equipment & Services
- United States
- Share Price
- $150.02 (yesterday's closing price)
- Shares in Issue
- 205 million
- Market Cap
- Market Indices
- S&P 500